Related Experiment Video
Updated: Nov 14, 2025

09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
5.9K
Risk factors for the delayed diagnosis of extrapulmonary TB
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul.
Summary
Diagnosing extrapulmonary tuberculosis (EPTB) is challenging. Delays stem from subtle symptoms and non-specialized clinic referrals, not the bacteria itself, impacting patient outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Extrapulmonary tuberculosis (EPTB) presents diagnostic challenges compared to pulmonary TB.
- Delayed EPTB management can result in severe complications and increased societal costs.
Purpose of the Study:
- To identify risk factors contributing to delayed diagnosis and treatment of extrapulmonary tuberculosis.
- To differentiate factors influencing early versus delayed EPTB diagnosis.
Main Methods:
- Retrospective analysis of 594 newly diagnosed EPTB patients across 11 South Korean general hospitals (Jan 2017–Dec 2018).
- Univariable and multivariable analyses compared early and delayed diagnosis groups to pinpoint risk factors.
- Patient characteristics and diagnostic test positivity were examined.
Main Results:
- Lymph node TB was the most common form (28.3%), followed by abdominal (18.4%) and disseminated TB (14.5%).
- Early diagnosis was linked to acute symptoms in disseminated, pericardial, and meningeal TB, and immunosuppression.
- Delayed diagnosis correlated with outpatient visits, delayed sample acquisition, and non-specialized diagnostic departments.
Conclusions:
- Diagnosis delays in EPTB are primarily attributed to indolent clinical presentations, leading to non-specialized care.
- Referral to non-TB-specialized departments and delayed diagnostic testing contribute significantly to EPTB treatment delays.
- Microbiological characteristics of Mycobacterium tuberculosis did not appear to influence diagnostic timelines.
Related Concept Videos
Pulmonary Tuberculosis IV
267
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
267
Pulmonary Tuberculosis I
487
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
487
Pulmonary Tuberculosis III
597
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
597
Pulmonary Tuberculosis II
850
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
850
Pulmonary Tuberculosis V
317
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
317
Other Pulmonary Disorders
1.1K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.1K

